BioCentury
ARTICLE | Financial News

Halozyme completes debt financing

February 1, 2016 8:00 AM UTC

Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine/Metabolic, Cancer, Dermatology Date completed: 2016-01-26 Type: Debt financing Raised: $150 million Investors: Pharmakon...